XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.1
Segments
3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Segments
  4. SEGMENTS

 

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision-maker is the CEO. The Company operates in and reports four business segments: property development, digital transformation technology, biohealth, and other business activities. The Company’s reportable segments are determined based on the services they perform and the products they sell, not on the geographic area in which they operate. The Company’s chief operating decision maker evaluates segment performance based on segment revenue. Costs excluded from segment income (loss) before taxes and reported as “Other” consist of corporate general and administrative activities which are not allocable to the four reportable segments.

 

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the three months ended March 31, 2021 and 2020:

 

    Property Development     Digital Transformation Technology     Biohealth Business     Other     Total  
                               
Three Months Ended March 31, 2021                                        
Revenue   $ 3,894,131     $ -     $ 1,712,783     $ -     $ 5,606,914  
Cost of Sales     (3,614,832 )     -       (83,022 )     -       (3,697,854 )
Gross Margin     279,299       -       1,629,761       -       1,909,060  
Operating Expenses     (359,489 )     (30,128 )     (846,480 )     (1,076,408 )     (2,312,505 )
Operating Income (Loss)     (80,190 )     (30,128 )     783,281       (1,076,408 )     (403,445 )
Other Income (Expense)     (9,873 )     (36,471 )     (8,371,117 )     (532,505 )     (8,949,966 )
Net Income (Loss) Before Income Tax     (90,063 )     (66,599 )     (7,587,836 )     (1,608,913 )     (9,353,411 )

 

    Property Development     Digital Transformation Technology     Biohealth Business     Other     Total  
                               
Three Months ended March 31, 2020                                        
Revenue   $ 2,954,389     $ -     $ 10,782     $ -     $ 2,965,171  
Cost of Sales     (2,380,820 )     -       (2,883 )     -       (2,383,703 )
Gross Margin     573,569       -       7,899       -       581,468  
Operating Expenses     (277,056 )     (18,228 )     (132,791 )     (575,784 )     (1,003,859 )
Operating Income (Loss)     296,513       (18,228 )     (124,892 )     (575,784 )     (422,391 )
Other Income (Expense)     7,539       (92,477 )     193       2,762,701       2,677,956  
Net Income (Loss) Before Income Tax     304,052       (110,705 )     (124,699 )     2,186,917       2,255,565  
                                         
March 31, 2021                                        
Cash and Restricted Cash   $ 9,842,218     $ 154,738     $ 3,251,622     $ 15,756,505     $ 29,005,083  
Total Assets     30,877,470       154,840       43,241,793       34,523,886       108,797,989  
                                         
December 31, 2020                                        
Cash and Restricted Cash   $ 8,150,769     $ 158,058     $ 1,590,265     $ 21,336,364     $ 31,235,456  
Total Assets     28,954,484       158,160       524,603       77,574,674       107,211,921